MS INTERNATIONAL PLC — Director's Dealing 2022

Jan 26, 2022

National Storage Mechanism | Additional information

RNS Number : 7352Z

SourceBio International PLC

26 January 2022

26 January 2022

SourceBio International plc

("SourceBio", the "Company" or the "Group")

Director/PDMR Shareholding

SourceBio International plc ("the Company") has been notified that on 26 January 2022, Harwood Capital LLP transferred 2,369 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Limited Partners of Harwood Private Equity IV L.P. ("HPE4") in order to satisfy distributions, in the normal course of business.

Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Harwood Capital LLP as investment manager

2

Reason for the notification

a)

Position/status

Christopher Mills is a non-executive director of the issuer and Chief Executive of the investment manager

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SourceBio International Plc

b)

LEI

213800KY4C9WU7WBW518

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of  £0.0015 each

Identification code

GB00BKSB1674

b)

Nature of the transaction

Transfer of shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
Nil	2,369

d)

Aggregated information

Volume

Price

N/A - single transaction

e)

Date of the transaction

26 January 2022

f)

Place of the transaction

Off market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVFLDIRFIF